Showing results (441-450 of 677) with videos related to
Sort By:
Pageof 68
Critical Care (London, England)|September 23, 2011
Red blood cell transfusion and outcomes in patients with acute lung injury, sepsis and shockElizabeth C Parsons, Catherine L Hough, Christopher W Seymour, et al.Anesthesiology|January 31, 2016
Use of Intensive Care Services for Medicare Beneficiaries Undergoing Major Surgical ProceduresHannah Wunsch, Hayley B Gershengorn, Colin R Cooke, et al.The Journal of Laboratory and Clinical Medicine|June 1, 1984
Effect of extracellular fluid volume depletion on renal regulation of acid-base and potassium equilibrium during prolonged mineral acid administrationH N Hulter, R D Toto, A Sebastian, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2004
Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantationArmin Gerbitz, Patricia Ewing, Andrea Wilke, et al.Journal of Hospital Medicine|April 26, 2018
Appraising the Evidence Supporting Choosing Wisely® RecommendationsAndrew J Admon, Ashwin Gupta, Margaret Williams, et al.Blood|April 8, 2004
Donor-derived TNF-alpha regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantationGerhard C Hildebrandt, Krystyna M Olkiewicz, Leigh A Corrion, et al.Experimental Hematology|January 3, 2007
Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host diseasePatricia Ewing, Sandra Miklos, Krystyna M Olkiewicz, et al.The Journal of Clinical Investigation|November 20, 1998
Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host diseaseK R Cooke, G R Hill, J M Crawford, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2003
Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effectShawn G Clouthier, Kenneth R Cooke, Takanori Teshima, et al.Journal of the Endocrine Society|December 29, 2022
Longitudinal Stability of Vitamin D Status and Its Association With Bone Mineral Density in Middle-aged AustraliansKun Zhu, Michael Hunter, Jennie Hui, et al.Pageof 68